* Click Here to download our Order Form
The webinar will cover the FDA’s new policy for laboratories that develop and begin to use validated COVID-19 diagnostics before the FDA has completed review of their Emergency Use Authorization (EUA) requests. The FDA can issue a EUA to permit the use, based on scientific data, of certain medical products that may be effective in diagnosing, treating, or preventing a disease or condition when there’s a determination, by HHS, that there is a public health emergency. The webinar will also cover the FDA’s new policy on the manufacture of Hand Sanitizers to respond to the Coronavirus crisis.
Learning Objectives:-
Why Should You Attend?
The audience will benefit by learning how laboratories can develop and begin to use validated COVID-19 diagnostics before the FDA has completed a review of their Emergency Use Authorization (EUA) requests. The FDA can issue a EUA to permit the use, based on scientific data, of certain medical products that may be effective in diagnosing, treating or preventing a disease or condition when there is a determination, by HHS, that there is a public health emergency or significant potential for a public health emergency like the Corona Virus. Companies that want to manufacture hand sanitizers according to new FDA standards will also greatly benefit from this presentation.
Who Will Benefit:-